Taisho Pharmaceutical Holdings Co 주식 주식분석 | 주식가격 | 뉴스 | 4581.T | JP3442850008 | A1JKG0

날짜	Taisho Pharmaceutical Holdings Co 주식 가격
	8,580.00 undefined
	8,590.00 undefined

날짜	Taisho Pharmaceutical Holdings Co 매출	Taisho Pharmaceutical Holdings Co EBIT	Taisho Pharmaceutical Holdings Co 이익
2027e	297.64 조. undefined	0 undefined	14.07 조. undefined
2026e	315.42 조. undefined	0 undefined	14.44 조. undefined
2025e	329.51 조. undefined	23.43 바이오. undefined	18.28 조. undefined
2024e	324.97 조. undefined	23.03 바이오. undefined	11.97 조. undefined
2023	301.38 조. undefined	23.02 조. undefined	19 조. undefined
2022	268.2 조. undefined	10.74 조. undefined	13.12 조. undefined
2021	281.98 조. undefined	19.97 조. undefined	13.32 조. undefined
2020	288.53 조. undefined	21.14 조. undefined	20.17 조. undefined
2019	261.55 조. undefined	31.21 조. undefined	48.59 조. undefined
2018	280.09 조. undefined	36.98 조. undefined	31.68 조. undefined
2017	279.77 조. undefined	31.97 조. undefined	28.78 조. undefined
2016	290.14 조. undefined	28.88 조. undefined	22.47 조. undefined
2015	290.5 조. undefined	31.97 조. undefined	24.53 조. undefined
2014	295.96 조. undefined	41.68 조. undefined	32.69 조. undefined
2013	285.17 조. undefined	35.34 조. undefined	26.32 조. undefined
2012	271.23 조. undefined	38.41 조. undefined	24.36 조. undefined

	매출	EBIT	이익
2012	271.23 조. JPY	38.41 조. JPY	24.36 조. JPY
2013	285.17 조. JPY	35.34 조. JPY	26.32 조. JPY
2014	295.96 조. JPY	41.68 조. JPY	32.69 조. JPY
2015	290.5 조. JPY	31.97 조. JPY	24.53 조. JPY
2016	290.14 조. JPY	28.88 조. JPY	22.47 조. JPY
2017	279.77 조. JPY	31.97 조. JPY	28.78 조. JPY
2018	280.09 조. JPY	36.98 조. JPY	31.68 조. JPY
2019	261.55 조. JPY	31.21 조. JPY	48.59 조. JPY
2020	288.53 조. JPY	21.14 조. JPY	20.17 조. JPY
2021	281.98 조. JPY	19.97 조. JPY	13.32 조. JPY
2022	268.2 조. JPY	10.74 조. JPY	13.12 조. JPY
2023	301.38 조. JPY	23.02 조. JPY	19 조. JPY
2024e	324.97 조. JPY	23.03 바이오. JPY	11.97 조. JPY
2025e	329.51 조. JPY	23.43 바이오. JPY	18.28 조. JPY
2026e	315.42 조. JPY	0 JPY	14.44 조. JPY
2027e	297.64 조. JPY	0 JPY	14.07 조. JPY

2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024e	2025e	2026e	2027e
271.23	285.17	295.96	290.5	290.14	279.77	280.09	261.55	288.53	281.98	268.2	301.38	324.97	329.51	315.42	297.64
-	5.14	3.78	-1.84	-0.12	-3.57	0.11	-6.62	10.31	-2.27	-4.89	12.37	7.83	1.40	-4.28	-5.64
63.50	61.81	62.40	61.36	61.00	63.71	65.31	65.13	62.43	62.39	61.09	59.01	-	-	-	-
172.23	176.26	184.68	178.26	176.99	178.25	182.94	170.35	180.14	175.93	163.83	177.85	0	0	0	0
0.04	0.04	0.04	0.03	0.03	0.03	0.04	0.03	0.02	0.02	0.01	0.02	23.03	23.43	0	0
14.16	12.39	14.08	11.01	9.95	11.43	13.20	11.93	7.33	7.08	4.01	7.64	7,086.24	7,111.10	-	-
24.36	26.32	32.69	24.53	22.47	28.78	31.68	48.59	20.17	13.32	13.12	19	11.97	18.28	14.44	14.07
-	8.06	24.21	-24.97	-8.38	28.07	10.07	53.39	-58.49	-33.99	-1.46	44.77	-37.00	52.73	-21.00	-2.60
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
82	81	81	81.11	80.96	79.96	79.95	79.89	79.9	79.91	81.54	82.09	0	0	0	0
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023

113.73	131.73	159.4	169.63	206.46	201.28	249.71	358.47	237.9	254.2	272.27	256.17
78.49	83.18	78.07	80.15	75.16	69.45	75.16	71.13	65.01	51.18	53.27	51.75
0	0	0	0	0	0	0	0	0	0	0	178
24.8	25.83	27.12	27.31	26.64	27.5	26.84	29.52	43.37	46.38	44.89	53.33
17.77	13.59	16.45	12	11.42	10.72	4.44	10.67	9.34	5.98	8.44	14.46
234.78	254.33	281.05	289.08	319.67	308.95	356.16	469.78	355.62	357.73	378.86	375.88
92.84	100.92	103.58	100.37	98.95	97.28	93.72	91.28	112.65	113.19	119.29	141.17
245.28	258.76	279.93	319.33	291.8	320.01	302.09	203.69	157.48	168.32	153.62	163.42
0	0	0	0	0	0	0	0	0	0	0	0
21.14	22.63	25.79	23.15	19.82	17.6	15.77	11.77	88.64	87.92	87.29	110.44
17.73	21.75	22.99	22.09	19.05	16.77	15.35	12.53	133.17	128.61	125.77	128.05
17.74	18.01	15.11	14.08	9.76	10.61	16.53	32.72	17.42	21.15	23.32	22.53
394.72	422.06	447.4	479.01	439.38	462.28	443.46	352	509.35	519.19	509.3	565.61
629.5	676.39	728.44	768.09	759.05	771.22	799.62	821.78	864.97	876.92	888.16	941.49

30	30	30	30	30	30	30	30	30	30	30	30
15	15.27	15.27	15.27	15.27	15.27	15.27	14.92	0	0.01	0	0
550.61	567.9	591.76	610	623.61	644.52	667.49	707.43	699	703.84	703.74	714.6
-11.08	-6.01	-1.85	2.37	-7.71	-8.36	-6.96	-2.76	-4.19	1.08	9.86	29.6
4.75	16.04	22.64	40.05	0	36.23	37.97	32.02	20.8	30.03	25.59	33.43
589.27	623.2	657.81	697.7	661.18	717.67	743.77	781.61	745.6	764.96	769.18	807.63
28.99	28.35	27.86	29.13	27.08	23.33	19.94	18.81	18.05	14.67	15.1	17
13.47	13.56	15.04	14.59	14.68	13.85	14.56	13.44	23.08	18.93	15.37	18.43
20.85	20.71	32.92	20.22	24.74	20.81	25.42	25.77	23.52	22.47	29.52	36.55
0	0.22	0.23	0.18	0.05	0.11	0.38	0.41	1.63	1.4	1.6	1.1
0	0	0	0	103	0	0	23	182	187	690	690
63.31	62.83	76.05	64.12	66.65	58.1	60.3	58.45	66.46	57.67	62.28	73.78
0	0	0	0.35	0.25	0	0	0.02	1.29	1	1.21	0.8
4.46	10.9	14.39	19.54	16.33	16.13	16.97	13.53	30.04	32.75	29.16	32.8
23.08	24.49	26.07	30.73	32.7	31.91	31.03	25.64	27.41	27.1	27.55	24.77
27.53	35.4	40.46	50.62	49.28	48.04	48	39.19	58.74	60.85	57.93	58.37
90.84	98.23	116.51	114.74	115.92	106.13	108.3	97.65	125.2	118.52	120.2	132.15
680.11	721.43	774.32	812.44	777.1	823.8	852.07	879.26	870.8	883.47	889.39	939.78

2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023
42.99	43.21	51.32	40.16	35.81	41.96	48.07	64.48	30.31	22.98	21.4	29.5
12.08	12.05	12.39	12.94	12.47	11.67	11.38	11.29	16.7	22.04	23.07	24.65
0	0	0	0	0	0	0	0	0	0	0	0
-25.5	-7.02	5.74	-10.9	1.29	-3.29	-8.61	-23.74	4.42	-0.15	-5.84	-7.78
-5,844	-8,039	-9,213	-8,718	-6,511	-10,268	-10,986	-32,856	-9,434	-2,842	-10,125	-5,392
11	17	2	2	2	1	2	2	119	173	158	173
16.84	8.45	7.05	16.42	9.18	11.34	11.68	14.93	14.14	6.19	8.69	10.21
23.73	40.21	60.23	33.48	43.06	40.07	39.85	19.18	41.99	42.03	28.51	40.97
-11,239	-12,681	-14,860	-5,764	-8,214	-8,830	-5,013	-4,914	-9,121	-14,372	-14,389	-50,379
-39.35	-9.36	-22	-18.16	-11.66	-1.36	-19.91	66.04	-107.08	-1.96	-7.06	-27.13
-28.11	3.32	-7.14	-12.4	-3.45	7.47	-14.9	70.96	-97.96	12.41	7.33	23.25
0	0	0	0	0	0	0	0	0	0	0	0
-239	-820	-121	-161	-236	-45	-103	-86	-1,337	-686	-254	-1,064
-15,079	-61	-110	-97	-10,097	-100	-96	-341	-48	-41	-43	-34
-23,073	-10,064	-9,439	-9,443	-19,525	-8,404	-9,867	-15,467	-11,696	-11,346	-10,057	-10,877
-330.00	-325.00	-314.00	-285.00	-289.00	-285.00	-897.00	-6,267.00	-725.00	-1,832.00	-2,345.00	-1,573.00
-7,425	-8,858	-8,894	-8,900	-8,903	-7,974	-8,771	-8,773	-9,586	-8,787	-7,415	-8,206
-39.13	21.65	30.02	6.9	11.23	29.95	10.14	69.19	-76.61	28.41	12.17	4.56
12,492	27,527	45,373	27,714	34,842	31,235	34,838	14,264	32,872	27,654	14,117	-9,407
0	0	0	0	0	0	0	0	0	0	0	0

Taisho Pharmaceutical Holdings Co 브루토마진	Taisho Pharmaceutical Holdings Co 이익 마진	Taisho Pharmaceutical Holdings Co EBIT-마진	Taisho Pharmaceutical Holdings Co 이익 마진
2027e	59.01 %	0 %	4.73 %
2026e	59.01 %	0 %	4.58 %
2025e	59.01 %	7,111.1 %	5.55 %
2024e	59.01 %	7,086.24 %	3.68 %
2023	59.01 %	7.64 %	6.3 %
2022	61.09 %	4.01 %	4.89 %
2021	62.39 %	7.08 %	4.72 %
2020	62.43 %	7.33 %	6.99 %
2019	65.13 %	11.93 %	18.58 %
2018	65.31 %	13.2 %	11.31 %
2017	63.71 %	11.43 %	10.29 %
2016	61 %	9.95 %	7.75 %
2015	61.36 %	11.01 %	8.44 %
2014	62.4 %	14.08 %	11.05 %
2013	61.81 %	12.39 %	9.23 %
2012	63.5 %	14.16 %	8.98 %

	브루토마진	EBIT-마진	이익 마진
2012	63.5 %	14.16 %	8.98 %
2013	61.81 %	12.39 %	9.23 %
2014	62.4 %	14.08 %	11.05 %
2015	61.36 %	11.01 %	8.44 %
2016	61 %	9.95 %	7.75 %
2017	63.71 %	11.43 %	10.29 %
2018	65.31 %	13.2 %	11.31 %
2019	65.13 %	11.93 %	18.58 %
2020	62.43 %	7.33 %	6.99 %
2021	62.39 %	7.08 %	4.72 %
2022	61.09 %	4.01 %	4.89 %
2023	59.01 %	7.64 %	6.3 %
2024e	59.01 %	7,086.24 %	3.68 %
2025e	59.01 %	7,111.1 %	5.55 %
2026e	59.01 %	0 %	4.58 %
2027e	59.01 %	0 %	4.73 %

날짜	Taisho Pharmaceutical Holdings Co 주당 매출	Taisho Pharmaceutical Holdings Co EBIT 당 주식	Taisho Pharmaceutical Holdings Co 주당 이익
2027e	3,631.18 undefined	0 undefined	171.59 undefined
2026e	3,848.15 undefined	0 undefined	176.18 undefined
2025e	4,020.04 undefined	0 undefined	223.01 undefined
2024e	3,964.6 undefined	0 undefined	146.02 undefined
2023	3,671.44 undefined	280.41 undefined	231.42 undefined
2022	3,289.3 undefined	131.75 undefined	160.93 undefined
2021	3,528.85 undefined	249.85 undefined	166.64 undefined
2020	3,611.1 undefined	264.54 undefined	252.47 undefined
2019	3,273.85 undefined	390.67 undefined	608.24 undefined
2018	3,503.3 undefined	462.5 undefined	396.23 undefined
2017	3,498.96 undefined	399.78 undefined	359.95 undefined
2016	3,583.86 undefined	356.71 undefined	277.6 undefined
2015	3,581.62 undefined	394.22 undefined	302.41 undefined
2014	3,653.79 undefined	514.6 undefined	403.6 undefined
2013	3,520.59 undefined	436.26 undefined	324.94 undefined
2012	3,307.68 undefined	468.45 undefined	297.04 undefined

	주당 매출	EBIT 당 주식	주당 이익
2012	3,307.68 JPY	468.45 JPY	297.04 JPY
2013	3,520.59 JPY	436.26 JPY	324.94 JPY
2014	3,653.79 JPY	514.6 JPY	403.6 JPY
2015	3,581.62 JPY	394.22 JPY	302.41 JPY
2016	3,583.86 JPY	356.71 JPY	277.6 JPY
2017	3,498.96 JPY	399.78 JPY	359.95 JPY
2018	3,503.3 JPY	462.5 JPY	396.23 JPY
2019	3,273.85 JPY	390.67 JPY	608.24 JPY
2020	3,611.1 JPY	264.54 JPY	252.47 JPY
2021	3,528.85 JPY	249.85 JPY	166.64 JPY
2022	3,289.3 JPY	131.75 JPY	160.93 JPY
2023	3,671.44 JPY	280.41 JPY	231.42 JPY
2024e	3,964.6 JPY	0 JPY	146.02 JPY
2025e	4,020.04 JPY	0 JPY	223.01 JPY
2026e	3,848.15 JPY	0 JPY	176.18 JPY
2027e	3,631.18 JPY	0 JPY	171.59 JPY

	주식 수량
2012	82 백만 Aktien
2013	81 백만 Aktien
2014	81 백만 Aktien
2015	81.11 백만 Aktien
2016	80.96 백만 Aktien
2017	79.96 백만 Aktien
2018	79.95 백만 Aktien
2019	79.89 백만 Aktien
2020	79.9 백만 Aktien
2021	79.91 백만 Aktien
2022	81.54 백만 Aktien
2023	82.09 백만 Aktien
2024e	82.09 백만 Aktien
2025e	82.09 백만 Aktien
2026e	82.09 백만 Aktien
2027e	82.09 백만 Aktien

날짜	Taisho Pharmaceutical Holdings Co 배당금
2027e	100.73 undefined
2026e	100.74 undefined
2025e	100.72 undefined
2024e	100.72 undefined
2023	100 undefined
2022	100 undefined
2021	100 undefined
2020	110 undefined
2019	60 undefined
2018	110 undefined
2017	110 undefined
2016	100 undefined
2015	110 undefined
2014	110 undefined
2013	110 undefined
2012	110 undefined

	배당금	배당금 (추정)
2012	110 JPY	0 JPY
2013	110 JPY	0 JPY
2014	110 JPY	0 JPY
2015	110 JPY	0 JPY
2016	100 JPY	0 JPY
2017	110 JPY	0 JPY
2018	110 JPY	0 JPY
2019	60 JPY	0 JPY
2020	110 JPY	0 JPY
2021	100 JPY	0 JPY
2022	100 JPY	0 JPY
2023	100 JPY	0 JPY
2024e	0 JPY	100.72 JPY
2025e	0 JPY	100.72 JPY
2026e	0 JPY	100.74 JPY
2027e	0 JPY	100.73 JPY

날짜	Taisho Pharmaceutical Holdings Co 배당률
2027e	58.57 %
2026e	57.74 %
2025e	58.84 %
2024e	59.13 %
2023	55.24 %
2022	62.14 %
2021	60.01 %
2020	43.57 %
2019	9.86 %
2018	27.76 %
2017	30.56 %
2016	36.02 %
2015	36.37 %
2014	27.25 %
2013	33.85 %
2012	37.03 %

	배당률
2012	37.03 %
2013	33.85 %
2014	27.25 %
2015	36.37 %
2016	36.02 %
2017	30.56 %
2018	27.76 %
2019	9.86 %
2020	43.57 %
2021	60.01 %
2022	62.14 %
2023	55.24 %
2024e	59.13 %
2025e	58.84 %
2026e	57.74 %
2027e	58.57 %

EPS-예상치	EPS-실제	보고 분기
82.55	35.04 (-57.55 %)	2024 Q3
61.66	37.66 (-38.92 %)	2024 Q2
53.02	53.23 (0.4 %)	2024 Q1
-10.77	-23.2 (-115.38 %)	2023 Q4
65.47	122.25 (86.71 %)	2023 Q3
35.95	62.52 (73.93 %)	2023 Q2
43.5	70.15 (61.27 %)	2023 Q1
33.82	50.59 (49.58 %)	2022 Q4
85	73.99 (-12.96 %)	2022 Q3
96.43	21.17 (-78.05 %)	2022 Q2
46.82	14.78 (-68.43 %)	2022 Q1
7.15	-11.51 (-260.96 %)	2021 Q4
50.62	36.84 (-27.22 %)	2021 Q3
54.58	65.53 (20.07 %)	2021 Q2
58.14	75.98 (30.68 %)	2021 Q1
50.25	32.59 (-35.14 %)	2020 Q4
106.29	36.96 (-65.23 %)	2020 Q3
93.56	49.77 (-46.8 %)	2020 Q2
91.11	137.91 (51.36 %)	2020 Q1
20.25	-35.14 (-273.54 %)	2019 Q4
137.92	112.31 (-18.57 %)	2019 Q3
363.28	360.12 (-0.87 %)	2019 Q2
68.92	171.5 (148.85 %)	2019 Q1
54.84	65.32 (19.11 %)	2018 Q4
113.76	180.81 (58.95 %)	2018 Q3
81.72	81.11 (-0.75 %)	2018 Q2
73.95	69.27 (-6.33 %)	2018 Q1
7.96	63.97 (703.76 %)	2017 Q4
99.85	127.28 (27.47 %)	2017 Q3
61.37	82.01 (33.64 %)	2017 Q2
56.87	86.92 (52.84 %)	2017 Q1
47.54	46.84 (-1.48 %)	2016 Q4
87.21	91.58 (5.01 %)	2016 Q3
66.2	81.35 (22.89 %)	2016 Q2
79.35	57.81 (-27.15 %)	2016 Q1
56.79	60.31 (6.19 %)	2015 Q4
72.11	82.13 (13.89 %)	2015 Q1
99.18	91.38 (-7.87 %)	2014 Q1
93.21	94.44 (1.32 %)	2013 Q1
35.96	42 (16.81 %)	2012 Q4

%-지분	이름	주식	변경
73.24 %	Otemon Co., Ltd.	60,034,194	60,034,194
4.76 %	Uehara Museum	3,900,000	0
2.61 %	Uehara (Akira)	2,143,000	0
2.01 %	Kajima Corp	1,650,000	0
1.58 %	Nomura Asset Management Co., Ltd.	1,295,095	-700
1.53 %	The Vanguard Group, Inc.	1,258,169	-8,800
1.44 %	Taisei KK	1,183,000	1,183,000
0.93 %	Norges Bank Investment Management (NBIM)	764,871	-105,620
0.85 %	Dai Nippon Printing Co Ltd	692,700	0
0.76 %	Nikko Asset Management Co., Ltd.	620,083	1,800
0.73 %	Daiwa Asset Management Co., Ltd.	598,920	289
0.55 %	Nissin Foods Holdings Co Ltd	453,900	0
0.41 %	Goldman Sachs Asset Management, L.P.	333,454	0
0.40 %	NEC Corp	330,000	0
0.38 %	BlackRock Institutional Trust Company, N.A.	314,500	-274,800
0.37 %	Toda Corp	300,000	0
0.37 %	Mochida Pharmaceutical Co Ltd	300,000	0
0.37 %	TOPPAN Holdings Inc	300,000	0
0.36 %	California Public Employees' Retirement System	297,800	7,500
0.35 %	Ezaki Glico Co Ltd	283,500	0
0.34 %	Mitsubishi UFJ Kokusai Asset Management Co., Ltd.	275,700	68,244
0.33 %	House Foods Group Inc	272,100	0
0.31 %	Toyo Seikan Group Holdings Ltd	255,000	0
0.31 %	Yamazaki Baking Co Ltd	255,000	0
0.29 %	Zeria Pharmaceutical Co Ltd	234,200	8,000
0.27 %	Dimensional Fund Advisors, L.P.	225,300	0
0.23 %	Casio Computer Co Ltd	187,800	0
0.20 %	Hisamitsu Pharmaceutical Co Inc	161,300	0
0.19 %	BlackRock Investment Management (UK) Ltd.	152,623	748
0.18 %	JP Morgan Asset Management	150,300	10,100
0.18 %	California State Teachers Retirement System	149,597	33,800
0.17 %	Nagatanien Holdings Co Ltd	138,300	0
0.16 %	Charles Schwab Investment Management, Inc.	127,748	-37,636
0.15 %	CPP Investment Board	123,000	0
0.14 %	Sumitomo Mitsui DS Asset Management Company, Limited	112,000	111,403
0.12 %	BlackRock Japan Co., Ltd.	94,600	7,200
0.09 %	BlackRock Advisors (UK) Limited	73,200	4,000
0.09 %	Kokuyo Co Ltd	71,000	0
0.08 %	State Street Global Advisors (US)	68,288	50,255
0.08 %	Mitsubishi UFJ Trust and Banking Corporation	68,200	68,200
0.08 %	MatsukiyoCocokara & Co	65,430	0
0.07 %	Mitsubishi HC Capital Inc	60,000	0
0.07 %	Legal & General Investment Management Ltd.	59,501	-500
0.07 %	Point Five Capital GmbH	56,000	10,000
0.07 %	Nissay Asset Management Corp.	53,373	999
0.06 %	Nippon Life Global Investors Singapore Limited	48,001	48,001
0.06 %	Asset Management One Co., Ltd.	47,421	0
0.05 %	Baillie Gifford & Co.	41,500	8,900
0.05 %	Mellon Investments Corporation	41,000	0
0.05 %	Geode Capital Management, L.L.C.	38,100	1,600
0.04 %	Nuveen LLC	34,500	-125,800
0.04 %	Macquarie Investment Management	32,100	-4,900
0.04 %	Storebrand Kapitalforvaltning AS	29,300	0
0.03 %	Fuji Glass Co Ltd	24,750	0
0.03 %	Handelsbanken Kapitalförvaltning AB	24,600	6,100
0.03 %	Toho Holdings Co Ltd	24,521	0
0.03 %	Kennox Asset Management Limited	24,300	0
0.03 %	HSBC Global Asset Management (UK) Limited	23,203	0
0.03 %	Mercer Global Investments Management Ltd	22,500	-33,400
0.03 %	Lazard Asset Management, L.L.C.	22,000	-2,600
0.03 %	Credit Suisse Funds AG	21,500	600
0.03 %	Amundi Asset Management, SAS	20,657	1,900
0.03 %	IndexIQ Advisors LLC	20,563	-2,584
0.02 %	PayPay Asset Management Corporation	19,200	-13,700
0.02 %	UBS Asset Management (UK) Ltd.	19,100	0
0.02 %	State Street Global Advisors (UK) Ltd.	18,277	-367
0.02 %	Dimensional Fund Advisors, Ltd.	17,300	0
0.02 %	Thrivent Asset Management, LLC	15,700	-10,900
0.02 %	Invesco Capital Management LLC	15,414	-2,540
0.02 %	PGGM Vermogensbeheer B.V.	14,319	-4,599
0.02 %	Monex Asset Management, Inc.	13,618	13,618
0.02 %	BlackRock Asset Management Canada Limited	12,900	0
0.01 %	Norinchukin Zenkyoren Asset Management Co., Ltd.	12,100	500
0.01 %	Florida State Board of Administration	11,352	-10,677
0.01 %	Franklin Templeton Portfolio Advisors, Inc	10,899	-9,684
0.01 %	Vanguard Investments Australia Ltd.	10,131	0
0.01 %	Zürcher Kantonalbank (Asset Management)	9,300	800
0.01 %	AQR Capital Management, LLC	8,400	-7,800
0.01 %	KLP Fondsforvaltning AS	8,300	0
0.01 %	Goldman Sachs Asset Management B.V.	7,900	200
0.01 %	Goldman Sachs Hedge Fund Strategies LLC	7,021	-663
0.01 %	BMO Asset Management Inc.	5,760	0
0.01 %	Simplex Asset Management Co., Ltd.	5,500	-9,200
0.01 %	Vanguard Global Advisers LLC	5,112	12
0.01 %	Royal London Asset Management Ltd.	4,500	0
0.01 %	AllianceBernstein L.P.	4,464	0
0.01 %	State Street Global Advisors Ireland Limited	4,300	0
0.01 %	Parametric Portfolio Associates LLC	4,300	0
0.00 %	Julius Baer Gestión, S.G.I.I.C., S.A.	3,900	3,900
0.00 %	WELCOME ASSET MANAGEMENT S.G.I.I.C., S.A	3,900	0
0.00 %	DWS Investment GmbH	3,440	0
0.00 %	abrdn Investments Limited	3,400	2,800
0.00 %	TD Asset Management Inc.	3,319	0
0.00 %	HSBC Global Asset Management (Hong Kong) Limited	2,400	1,400
0.00 %	Pictet Asset Management Ltd.	2,000	0
0.00 %	GLG Partners LP	1,991	1,393
0.00 %	Janus Henderson Investors	1,800	0
0.00 %	American Century Investment Management, Inc.	1,700	0
0.00 %	Schroder Investment Management Ltd. (SIM)	1,700	-6,700
0.00 %	Mackenzie Financial Corporation	1,694	85

이름	관계	이주간 상관관계	원월 상관관계	삼개월 상관계수	여섯달 상관관계	일년간 상관관계	이년 상관관계
Mochida Pharmaceutical	공급업체고객	0,85	0,78	0,78	0,60	0,10	0,70
Teijin	공급업체고객	0,52	0,83	0,23	0,20	0,71	0,85
FUJIFILM Holdings	공급업체고객	0,51	0,56	0,17	0,08	0,57	-0,43
Johnson & Johnson	공급업체고객	0,50	0,55	-0,65	-0,50	-0,43	-0,54
Moberg Pharma	공급업체고객	0,48	0,37	0,84	0,62	0,75	0,48
Yomeishu Seizo	공급업체고객	0,37	0,05	0,82	0,62	0,86	0,84
Chugai Pharmaceutical	공급업체고객	0,27	0,23	0,16	0,17	0,58	0,65
Procter & Gamble	공급업체고객	0,23	0,47	-0,67	-0,37	-0,73	-0,75
MediciNova	공급업체고객	0,03	0,15	-0,07	-0,07	0,73	0,75
Mitsui Chemicals	공급업체고객	0,02	-0,03	0,07	0,05	0,75	0,03

What values and corporate philosophy does Taisho Pharmaceutical Holdings Co represent?

Taisho Pharmaceutical Holdings Co Ltd represents a strong commitment to providing quality healthcare products and improving the well-being of individuals. Their corporate philosophy revolves around innovation, ethical practices, and customer satisfaction. With a focus on research and development, Taisho Pharmaceutical aims to create cutting-edge solutions that address various health concerns. The company's values include integrity, respect for diversity, and a dedication to social responsibility. By combining their expertise with a customer-centered approach, Taisho Pharmaceutical strives to make a positive impact on society through their pharmaceutical and healthcare offerings.

In which countries and regions is Taisho Pharmaceutical Holdings Co primarily present?

Taisho Pharmaceutical Holdings Co Ltd is primarily present in Japan.

What significant milestones has the company Taisho Pharmaceutical Holdings Co achieved?

Taisho Pharmaceutical Holdings Co Ltd has achieved several significant milestones throughout its history. One notable milestone was the acquisition of Bristol-Myers Squibb's OTC drug business in 2009, expanding its product portfolio and market presence. In 2011, Taisho successfully launched its flagship product, Lipovitan D, a popular energy drink that quickly gained popularity in the Japanese market. Additionally, the company has consistently focused on research and development, leading to the introduction of innovative pharmaceutical products. Taisho Pharmaceutical Holdings Co Ltd continues to foster strategic partnerships and expand its global presence, making it a leading player in the healthcare industry.

What is the history and background of the company Taisho Pharmaceutical Holdings Co?

Taisho Pharmaceutical Holdings Co Ltd is a renowned pharmaceutical company with a rich history and notable background. Established in 1912, the company has been dedicated to improving healthcare and enhancing the well-being of individuals worldwide. With its headquarters in Tokyo, Japan, Taisho Pharmaceutical Holdings has expanded its operations to various countries, including the United States, China, and Southeast Asia. The company specializes in the research, development, manufacturing, and sales of a wide range of pharmaceutical products, including prescription drugs, OTC medications, and health-related products. Taisho Pharmaceutical Holdings Co Ltd has continuously strived for innovation and excellence, earning a reputation as a leading player in the global pharmaceutical industry.

Who are the main competitors of Taisho Pharmaceutical Holdings Co in the market?

The main competitors of Taisho Pharmaceutical Holdings Co Ltd in the market are Takeda Pharmaceutical Company Limited, Pfizer Inc., and GlaxoSmithKline plc.

In which industries is Taisho Pharmaceutical Holdings Co primarily active?

Taisho Pharmaceutical Holdings Co Ltd is primarily active in the pharmaceutical industry.

What is the business model of Taisho Pharmaceutical Holdings Co?

The business model of Taisho Pharmaceutical Holdings Co Ltd revolves around the development, manufacture, and sale of pharmaceutical products. As a leading Japanese pharmaceutical company, Taisho focuses on research and innovation to provide high-quality medications to improve people's health and well-being. The company specializes in therapeutic areas such as internal medicine, dermatology, and nutraceuticals. Taisho Pharmaceutical Holdings Co Ltd strives to establish a strong presence in both domestic and international markets, ensuring accessibility to their diverse range of healthcare products. With a dedication to advancing medical solutions, Taisho remains committed to addressing society's healthcare needs effectively.

Taisho Pharmaceutical Holdings Co 2024의 P/E 비율은 얼마입니까?

Taisho Pharmaceutical Holdings Co의 P/E 비율은 58.85입니다.

Taisho Pharmaceutical Holdings Co 2024의 KUV는 얼마입니까?

Taisho Pharmaceutical Holdings Co의 P/S 비율은 2.17입니다.

Taisho Pharmaceutical Holdings Co의 AlleAktien 품질 점수는 얼마인가요?

Taisho Pharmaceutical Holdings Co에 대한 AlleAktien 품질 점수는 2/10입니다.

Taisho Pharmaceutical Holdings Co 2024의 매출은 얼마인가요?

예상되는 Taisho Pharmaceutical Holdings Co 매출은 324.97 조. JPY입니다.

Taisho Pharmaceutical Holdings Co 2024의 이익은 얼마인가요?

예상되는 Taisho Pharmaceutical Holdings Co 이익은 11.97 조. JPY입니다.

Taisho Pharmaceutical Holdings Co은 무엇을 하나요?

Taisho Pharmaceutical Holdings Co Ltd is a Japanese company active in the pharmaceutical, healthcare, and cosmetics sectors. The company was established in 1912 and has its headquarters in Tokyo, Japan. The business model of Taisho Pharmaceutical focuses on the development, production, and sale of innovative products aimed at improving people's health and well-being. The company operates three main business fields: pharmaceuticals, healthcare, and cosmetics. In the pharmaceutical business, Taisho Pharmaceutical manufactures and distributes medications used to treat diseases and ailments. The company has a wide range of medications for cardiovascular diseases, diabetes, pain and inflammation, as well as viral and bacterial infections. The company utilizes advanced technologies and places a major emphasis on research and development to consistently bring the best medication to the market. The healthcare business of Taisho Pharmaceutical includes a range of products aimed at maintaining people's health and well-being. The company offers dietary supplements, vitamins, sports and fitness products, as well as health monitoring devices. These products are sold through various distribution channels such as pharmacies, drugstores, and online shops. In the cosmetics field, Taisho Pharmaceutical offers a wide range of products including skincare, haircare, and makeup products. The company has developed its cosmetics products using its pharmaceutical technologies and research to create the best products. These products are sold both in the Japanese market and internationally. In conclusion, Taisho Pharmaceutical's business model is focused on innovation, research, and development. The company aims to improve people's health and well-being by developing innovative products that cater to customer needs. With its diverse range of products and services, Taisho Pharmaceutical successfully operates in the pharmaceutical, healthcare, and cosmetics industries and will continue to serve customers worldwide in the future.

Taisho Pharmaceutical Holdings Co 배당금은 얼마입니까?

Taisho Pharmaceutical Holdings Co은(는) 연간 번의 배당을 통해 100 JPY의 배당금을 지급합니다.

Taisho Pharmaceutical Holdings Co이 얼마나 자주 배당을 지급하나요?

Taisho Pharmaceutical Holdings Co의 현재 배당금은 계산할 수 없거나, 회사가 배당금을 지급하지 않습니다.

Taisho Pharmaceutical Holdings Co ISIN이 무엇입니까?

Taisho Pharmaceutical Holdings Co의 ISIN은 JP3442850008입니다.

Taisho Pharmaceutical Holdings Co WKN은 무엇인가요?

Taisho Pharmaceutical Holdings Co의 WKN은 A1JKG0입니다.

Taisho Pharmaceutical Holdings Co 티커는 무엇인가요?

Taisho Pharmaceutical Holdings Co의 티커는 4581.T입니다.

Taisho Pharmaceutical Holdings Co이 얼마만큼의 배당금을 지급합니까?

지난 12개월 동안 Taisho Pharmaceutical Holdings Co은(는) 100 JPY 의 배당금을 지급했습니다. 이는 약 1.17 %의 배당 수익률에 해당합니다. 향후 12개월 동안 Taisho Pharmaceutical Holdings Co은(는) 100.72 JPY의 배당금을 지급할 것으로 예상됩니다.

Taisho Pharmaceutical Holdings Co의 배당 수익률은 얼마입니까?

Taisho Pharmaceutical Holdings Co의 현재 배당 수익률은 1.17 %입니다.

Taisho Pharmaceutical Holdings Co의 배당금은 언제 지급되나요?

Taisho Pharmaceutical Holdings Co은 분기별로 배당금을 지급합니다. 이는 , , , 월에 배당됩니다.

Taisho Pharmaceutical Holdings Co의 배당금은 얼마나 안전한가요?

Taisho Pharmaceutical Holdings Co은(는) 지난 16년 동안 매년 배당금을 지급했습니다.

Taisho Pharmaceutical Holdings Co의 배당금은 얼마입니까?

향후 12개월 동안 100.72 JPY의 배당금이 예상됩니다. 이는 배당수익률 1.17 %에 해당합니다.

Taisho Pharmaceutical Holdings Co이(가) 속해 있는 섹터는 어디인가요?

Taisho Pharmaceutical Holdings Co은 '건강' 섹터에 속합니다.

Wann musste ich die Aktien von Taisho Pharmaceutical Holdings Co kaufen, um die vorherige Dividende zu erhalten?

Taisho Pharmaceutical Holdings Co의 마지막 배당금을 50 JPY만큼 받기 위해선 의 Ex-Tag 전에 주식을 보유하고 있어야 했습니다.

Taisho Pharmaceutical Holdings Co의 마지막 배당금 지급일은 언제였습니까?

마지막 배당금 지급일은 입니다.

Taisho Pharmaceutical Holdings Co의 2023년도 배당금은 얼마였습니까?

2023년에 Taisho Pharmaceutical Holdings Co는 100 JPY를 배당금으로 지급했습니다.

Taisho Pharmaceutical Holdings Co는 어떤 화폐로 배당금을 지급하나요?

Taisho Pharmaceutical Holdings Co의 배당금은 JPY에 지급됩니다.

Scope 1 - 직접 방출	22,353
스코프 2 - 구매한 에너지로부터의 간접적인 배출	27,732
Scope 3 - 가치 창출 체인 내의 간접 배출	145,850
총 CO₂ 배출량	50,085
CO₂ 감소 전략	✅
석탄 에너지	❌
원자력	❌
동물 실험	✅
펠츠 & 레더	—
살충제	—
팜 오일	—
담배	❌
유전자 변형 생물체	❌
기후 개념	—
지속 가능한 임업	—
재활용 규정	❌
환경 친화적인 포장	✅
위험물질	❌
연료 소비량과 효율성	✅
물 사용량 및 효율성	✅

여성 직원 비율	—
관리 직위에서의 여성 비율	—
아시아 직원 비율	—
아시아 경영진 비율	—
히스패닉/라티노 직원 비율	—
히스패닉/라티노 관리 부문 지분	—
흑인 직원 비율	—
블랙 매니지먼트 지분	—
흰색 종업원의 비율	—
화이트 매니지먼트 지분	—
성인 콘텐츠	❌
알코올	✅
무기	—
총기	❌
도박	❌
군사 계약	❌
인권 개념	✅
개인정보 보호 정책	—
작업 및 건강 보호	✅
카톨릭	✅

환경 보고	✅
이해관계자 참여	❌
콜백 정책	❌
카르텔법	❌

증권거래소	Taisho Pharmaceutical Holdings Co 티커
JPX	4581.T
PNK	TAISF

Taisho Pharmaceutical Holdings Co 티커	Taisho Pharmaceutical Holdings Co FIGI
4581:JP	BBG0021NMNF2
4581:JT	BBG0021NMNG1
4581:JJ	BBG0021NMNR9
4581:JE	BBG0021NMNV4
4581:JI	BBG0021NMNW3
4581:JU	BBG002QKJGR7
TAISF:US	BBG005Y0QL96
TAISF:PQ	BBG005Y0QLQ7
TAISF:UV	BBG005Y0QLS5
4581:JW	BBG00875LB14
4581JPY:X2	BBG00JQDMH45
4581JPY:XB	BBG00JQDMH54
4581JPY:XH	BBG00JQDMH72
4581JPY:XF	BBG00JQDMH90
4581JPY:XE	BBG00JQDMHC6
4581JPY:XJ	BBG00JQDMHD5
4581JPY:XL	BBG00JQDMHF3
4581JPY:XG	BBG00JQDMHG2
4581JPY:XO	BBG00JQDMHH1
4581JPY:XS	BBG00JQDMHM5
4581JPY:XA	BBG00JQDMHN4
4581JPY:E1	BBG00JQDMHP2
4581JPY:XT	BBG00JQDMHQ1
4581JPY:XW	BBG00JQDMHR0
4581JPY:XU	BBG00JQDMHS9
4581JPY:XV	BBG00JQDMHT8
4581JPY:XM	BBG00JQDMHV5
4581JPY:XQ	BBG00JQDMHX3
4581JPY:XX	BBG00JQDMHY2
4581JPY:XZ	BBG00JQDMHZ1
4581JPY:EU	BBG00JQDMJ14
4581USD:EO	BBG00KDP0F83
4581USD:XH	BBG00KDP0FC8
4581USD:XF	BBG00KDP0FF5
4581USD:XE	BBG00KDP0FH3
4581USD:XJ	BBG00KDP0FJ1
4581USD:XL	BBG00KDP0FK9
4581USD:XG	BBG00KDP0FL8
4581USD:XO	BBG00KDP0FM7
4581USD:XS	BBG00KDP0FR2
4581USD:XA	BBG00KDP0FS1
4581USD:E1	BBG00KDP0FT0
4581USD:XT	BBG00KDP0FV7
4581USD:XW	BBG00KDP0FW6
4581USD:XU	BBG00KDP0FX5
4581USD:XV	BBG00KDP0FY4
4581USD:XM	BBG00KDP0FZ3
4581USD:XQ	BBG00KDP0G18
4581USD:XX	BBG00KDP0G27
4581USD:XZ	BBG00KDP0G36
4581USD:EU	BBG00KDP0G54
4581EUR:EO	BBG00KDZDDX4
4581EUR:XH	BBG00KDZDF05
4581EUR:XF	BBG00KDZDF23
4581EUR:XE	BBG00KDZDF41
4581EUR:XJ	BBG00KDZDF50
4581EUR:XL	BBG00KDZDF69
4581EUR:XG	BBG00KDZDF78
4581EUR:XO	BBG00KDZDF87
4581EUR:XS	BBG00KDZDFD1
4581EUR:XA	BBG00KDZDFF9
4581EUR:E1	BBG00KDZDFG8
4581EUR:XT	BBG00KDZDFH7
4581EUR:XW	BBG00KDZDFJ5
4581EUR:XU	BBG00KDZDFK3
4581EUR:XV	BBG00KDZDFL2
4581EUR:XM	BBG00KDZDFM1
4581EUR:XQ	BBG00KDZDFP8
4581EUR:XX	BBG00KDZDFQ7
4581EUR:XZ	BBG00KDZDFR6
4581EUR:EU	BBG00KDZDFT4
4581JPY:EP	BBG00QS0J894
4581JPY:EZ	BBG00QS0J8C0
4581:JV	BBG0193RCR49

한 눈에 저평가된 주식을 인식하세요 fair value · 20 million securities worldwide · 50 year history · 10 year estimates · leading business news

가격

가격

티커4581.T

ISINJP3442850008

WKNA1JKG0

Taisho Pharmaceutical Holdings Co 주식 가격

가격

개요

인트라데이 기능

총 수익률 및 상대 가격 변동

해석 및 투자

Taisho Pharmaceutical Holdings Co 주가 이력

Taisho Pharmaceutical Holdings Co 주식 매출, EBIT, 이익 JP3442850008 · A1JKG0

매출, 이익 & EBIT

매출, EBIT, 소득 이해하기

연간 분석 및 비교

투자 기대치 활용

투자 통찰력

Taisho Pharmaceutical Holdings Co 매출, 이익 및 EBIT 역사

Taisho Pharmaceutical Holdings Co 주식 지표

손익계산서

매출 성장

총 이익률

EBIT와 EBIT 마진

수입과 성장

발행 주식

연간 비교의 해석

기대치와 예측

재무 상태표

재무 상태표 이해

자산

부채

자본

년대비 분석

데이터 해석

Taisho Pharmaceutical Holdings Co 주식 마진 JP3442850008 · A1JKG0

마진

매출 총이익률 이해

EBIT 마진 분석

매출 마진에 대한 인사이트

기대치 해석

비교 분석

Taisho Pharmaceutical Holdings Co 마진 역사

Taisho Pharmaceutical Holdings Co 주식 매출, EBIT, 주당 순이익 JP3442850008 · A1JKG0

매출, EBIT 및 주당 이익

주당 매출

주당 EBIT

주당 수익

예상 값

Taisho Pharmaceutical Holdings Co 매출, 이익 및 EBIT 주당 역사

Taisho Pharmaceutical Holdings Co 주식 및 주식 분석

Taisho Pharmaceutical Holdings Co Fair Value에 따른 평가

Fair Value

Fair Value 이해하기

수익 기반 Fair Value

매출 기반 Fair Value

배당 기반 Fair Value

기대치와 예측

비교 분석

Taisho Pharmaceutical Holdings Co 역사적인 P/E, EBIT 및 P/S에 따른 평가

Taisho Pharmaceutical Holdings Co 주식 수량 JP3442850008 · A1JKG0

매출, EBIT 및 주당 이익

주당 매출

주당 EBIT

주당 수익

예상 값

Taisho Pharmaceutical Holdings Co 주식 배당금 JP3442850008 · A1JKG0

배당금

배당금에 대한 개요

해석 및 사용

투자 전략

Taisho Pharmaceutical Holdings Co 배당금 내역

Taisho Pharmaceutical Holdings Co 주식 배당률 JP3442850008 · A1JKG0

배당비율

연간 배당비율이란 무엇인가요?

데이터 해석 방법

투자에 대한 데이터 사용

Taisho Pharmaceutical Holdings Co 배당금지급률 역사

Taisho Pharmaceutical Holdings Co 수익 예상

한 눈에 저평가된 주식을 인식하세요
fair value · 20 million securities worldwide · 50 year history · 10 year estimates · leading business news

티커
4581.T

ISIN
JP3442850008

WKN
A1JKG0